KR20210120761A - A drug system that sterilizes viruses by intravenously injecting substances generated by oxidation reaction of hydrogen peroxide - Google Patents

A drug system that sterilizes viruses by intravenously injecting substances generated by oxidation reaction of hydrogen peroxide Download PDF

Info

Publication number
KR20210120761A
KR20210120761A KR1020200038156A KR20200038156A KR20210120761A KR 20210120761 A KR20210120761 A KR 20210120761A KR 1020200038156 A KR1020200038156 A KR 1020200038156A KR 20200038156 A KR20200038156 A KR 20200038156A KR 20210120761 A KR20210120761 A KR 20210120761A
Authority
KR
South Korea
Prior art keywords
hydrogen peroxide
generated
oxidation reaction
drug system
sterilizes
Prior art date
Application number
KR1020200038156A
Other languages
Korean (ko)
Inventor
석 규 이
이광석
Original Assignee
석 규 이
이광석
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 석 규 이, 이광석 filed Critical 석 규 이
Priority to KR1020200038156A priority Critical patent/KR20210120761A/en
Publication of KR20210120761A publication Critical patent/KR20210120761A/en

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates to a drug system for sterilizing viruses by intravenously injecting substances generated by oxidation reaction of hydrogen peroxide, as an injectable drug system, in which the substance (3) generated by the oxidation reaction of hydrogen peroxide containing oxygen generated by reacting hydrogen peroxide with iron oxide or hemoglobin is mixed with distilled water for injection (1), sterilized and packaged (2), and intravenously injected into an animal or human, thereby sterilizing viruses to treat infected diseases. Accordingly, provided is a drug system for sterilizing viruses by intravenously injecting substances generated by the oxidation reaction of hydrogen peroxide, which is manufactured by mixing the substance (3) generated by the oxidation reaction of hydrogen peroxide containing oxygen generated by reacting hydrogen peroxide with iron oxide or hemoglobin in distilled water for injection (1) and carrying out sterile packaging (2).

Description

과산화수소를 산화반응시켜 발생한 물질을 정맥주사하여 바이러스를 멸균시키는 약재시스템{omitted}A drug system that sterilizes viruses by intravenously injecting substances generated by oxidizing hydrogen peroxide {omitted}

본 발명은 과산화수소를 산화철분 또는 헤모글로빈에 반응시켜 발생한 산소를 포함한 과산화수소를 산화반응시켜 발생한 물질(3)을 주사용증류수(1)에 혼재시켜 멸균포장(2)하여 제조하고 동물이나 인체의 정맥에 주사하여 감염된 바이러스를 멸균시켜 감염된 질환을 치료하는 주사약품 시스템 으로써The present invention is prepared by mixing a substance (3) generated by an oxidative reaction of hydrogen peroxide containing oxygen generated by reacting hydrogen peroxide with iron oxide or hemoglobin in distilled water for injection (1), sterilized and packaged (2), and administered to an animal or human vein. It is an injection drug system that sterilizes the infected virus by injection and treats the infected disease.

과산화수소를 산화반응시켜 발생한 물질을 정맥주사하여 바이러스를 멸균시키는 약재시스템인에 관한 것이다It relates to a drug system that sterilizes viruses by intravenously injecting substances generated by oxidizing hydrogen peroxide.

본 발명은 감염원인 변종 또는 신종바이러스를 정맥주사하여 멸균시켜 생명을 구하는 것으로The present invention is to save lives by sterilizing a mutant or novel virus that is the cause of infection by intravenous injection.

종래에는 인체에 감염된 변종 또는 신종바이러스에 대하여 즉시 치료대책이 없는 큰단점이 있다Conventionally, there is a big disadvantage that there is no immediate treatment measures for a mutant or new virus infected with the human body.

본 발명은 상기한 종래의 문제점을 해소하기 위하여The present invention in order to solve the above conventional problems

인체에 감염원인 변종 또는 신종바이러스를 정맥주사하여 멸균시켜 생명을 구하는 것으로써,By intravenously injecting a mutant or new virus that causes infection into the human body and sterilizing it, it saves lives.

과산화수소를 산화반응시켜 발생한 물질을 정맥주사하여 바이러스를 멸균시키는 약재시스템을 제공 하는데 목적이 있다The purpose of this is to provide a drug system that sterilizes viruses by intravenously injecting substances generated by oxidizing hydrogen peroxide.

본 발명은 과산화수소를 산화반응시켜 발생한 물질을 정맥주사하여 바이러스를 멸균시키는 약재시스템을 제공하여 목적을 달성한다The present invention achieves the object by providing a pharmaceutical system for sterilizing viruses by intravenously injecting a substance generated by oxidizing hydrogen peroxide.

본 발명은 과산화수소를 산화반응시켜 발생한 물질을 정맥주사하여 바이러스를 멸균시키는 약재시스템에 관한 것 으로써The present invention relates to a pharmaceutical system for sterilizing viruses by intravenously injecting a substance generated by an oxidation reaction of hydrogen peroxide.

과산화수소를 산화철분 또는 헤모글로빈에 반응시켜 발생한 산소를 포함한 과산화수소를 산화반응시켜 발생한 물질(3)을 주사용증류수(1)에 혼재시켜 멸균포장(2)하여 제조하고 동물이나 인체의 정맥에 주사하여 감염된 바이러스를 멸균시켜 감염된 질환을 치료하는 주사약품 시스템을 제공하여 치료하고 생명을 탁월하게 구하는 큰 장점이 있다The substance (3) generated by the oxidation reaction of hydrogen peroxide containing oxygen generated by reacting hydrogen peroxide with iron oxide or hemoglobin is mixed with distilled water for injection (1), sterilized and packaged (2), and manufactured by injecting into an animal or human vein. It has the great advantage of providing an injection drug system that sterilizes viruses to treat infected diseases and saves lives.

또한, 세균이나 바이러스가 유행하면 동물이나 인체의 정맥에 본발명의 약품을 미리 주사하여 혈관과 세포에 흡습시켜 바이러스가 침투하여 활성화 되지 않도록 방어하는 큰 장점을 제공한다In addition, when bacteria or viruses are prevalent, the drug of the present invention is pre-injected into veins of animals or the human body to absorb moisture into blood vessels and cells, thereby providing a great advantage of defending against intrusion and activation of viruses.

또한, 국가비상사태 발생시에 세균전에 감염되지 않도록 미리 경구투여하거나 정맥에 주사하여 세균전에 피해가 없거나 감소하는 효과를 제공하는 큰 장점이 있다In addition, in case of a national emergency, oral administration or intravenous injection in advance to prevent infection with bacterial warfare has a great advantage in providing the effect of eliminating or reducing damage to bacterial warfare.

또한,과산화수소를 산화반응시켜 발생한 물질을 정맥주사하여 바이러스를 멸균시키는 약재시스템을 제공하는 큰 장점이 있다In addition, there is a great advantage of providing a drug system that sterilizes viruses by intravenously injecting a substance generated by oxidizing hydrogen peroxide.

도1은 본 발명의 따른,
과산화수소를 산화반응시켜 발생한 물질을 정맥주사하여 바이러스를 멸균시키는 약재시스템을 개략적으로 도시한 구조도
※ 도면의 주요 부분에 부호의 설명
1: 주사용증류수 2: 멸균포장
3: 산화반응시켜 발생한 물질1 is according to the present invention,
Structural diagram schematically showing a drug system that sterilizes viruses by intravenously injecting substances generated by oxidizing hydrogen peroxide
※ Explanation of symbols in the main parts of the drawing
1: Distilled water for injection 2: Sterile packaging
3: Substances generated by oxidation reaction

이하, 첨부된 도면을 참조하여 본 발명을 한정하지 않는 바람직한 실시예를 상세히 설명한다.Hereinafter, preferred embodiments without limiting the present invention will be described in detail with reference to the accompanying drawings.

도1은 본 발명은 과산화수소를 산화반응시켜 발생한 물질을 정맥주사하여 바이러스를 멸균시키는 약재시스템을 개략적으로 도시한 구조도이고,1 is a structural diagram schematically showing a drug system for sterilizing a virus by intravenously injecting a substance generated by an oxidation reaction of hydrogen peroxide;

"구체적으로 살펴보면 아래와 같다.""If you look at it in detail, it's as follows."

본 발명의 제조단계를 나열하자면Let's list the manufacturing steps of the present invention

첫째, 35%이하의 과산화수소를 중량대비 80% 이상으로 하고 산화철분 또는 헤모글로빈을 중량대비20% 이하로 반응 용기에 담아 혼재하면서 반응시켜 산화반응시켜 발생한 물질(3)을 추출하는 단계 와First, 35% or less of hydrogen peroxide is made 80% or more by weight, and iron oxide or hemoglobin is placed in a reaction vessel at 20% or less by weight and reacted while mixing to extract the material (3) generated by oxidation reaction;

둘째, 산화반응시켜 발생한 물질(3)을 추출하여 주사용증류수(1)에 혼재시켜 멸균포장(2)하여 완성약품을 제조하는 단계로 제조 된 것이며Second, the material (3) generated by the oxidation reaction is extracted, mixed in distilled water for injection (1), and sterilized and packaged (2) to manufacture the finished drug.

제조 된 완성약품을 동물이나 인체의 정맥에 주사하여 감염된 바이러스를 멸균시켜 감염된 질환을 치료하는 주사약품 시스템을 특징으로 하는It features an injection drug system that sterilizes the infected virus by injecting the manufactured finished drug into a vein of an animal or human body to treat an infected disease.

과산화수소를 산화반응시켜 발생한 물질을 정맥주사하여 바이러스를 멸균시키는 약재시스템 인 것이다It is a drug system that sterilizes the virus by intravenously injecting the substance generated by the oxidation reaction of hydrogen peroxide.

또한,본발명은 산화반응시켜 발생한 물질(3)을 인체 장기에 흐르는 혈액의 흐름을 따라 이송시켜 인체의 세포에 물질이동시켜 흡습시키고 용존산소량을 대폭증대시켜 세포의 염증물질을 제거하면서 세포의 면역력을 극대화 시키는 기능과In addition, the present invention transports the material (3) generated by oxidation reaction along the flow of blood flowing through the human body, moves the material to the cells of the body to absorb moisture, and greatly increases the amount of dissolved oxygen to remove the inflammatory material of the cell and the immunity of the cell function to maximize

장기내 상처를 보호 하고 세포의 2차감염을 탁월하게 방지하는 기능과The function of protecting internal wounds and excellently preventing secondary infection of cells and

세균이나 변종 또는 신종바이러스의 단백질을 파괴하여 변종 또는 신종바이러스 활동 할 수 없는 조건을 제시하여 멸균시키는 기능과 동시에 발생된 산소는Oxygen generated at the same time as the function of sterilizing by destroying the protein of bacteria, mutant or new virus by presenting conditions in which the mutant or new virus cannot act

폐를 비롯한 호흡기에 자연분산 공급시켜 생명을 구하는 기능으로 이루어지며 멸균된 세균이나 변종 또는 신종바이러스를 대변과 소변으로 방출시키는 것을 특징으로 하는It has a life-saving function by naturally dispersing supply to the respiratory tract including the lungs, and it is characterized by releasing sterilized bacteria, mutants, or new viruses into feces and urine.

과산화수소를 산화반응시켜 발생한 물질(3)을 정맥주사하여 바이러스를 멸균시키는 약재시스템 인 것이다It is a drug system that sterilizes the virus by intravenously injecting the substance (3) generated by the oxidation reaction of hydrogen peroxide.

또한, 과산화수소를 산화반응시켜 발생한 물질(3)을 약품으로 제조하여 정맥주사 하였을때 혈액에 잔류하는 미량의 과산화수소 성분은 혈액이 보유한 염소에 의하여 중화되고 배설물로 배출되는 것을 특징으로 하는In addition, when the substance (3) generated by the oxidation reaction of hydrogen peroxide is manufactured as a drug and injected intravenously, a trace amount of hydrogen peroxide component remaining in the blood is neutralized by chlorine in the blood and discharged as excrement.

과산화수소를 산화반응시켜 발생한 물질(3)을 정맥주사하여 바이러스를 멸균시키는 약재시스템 인 것이다It is a drug system that sterilizes the virus by intravenously injecting the substance (3) generated by the oxidation reaction of hydrogen peroxide.

또한, 본 발명은 청구범위 요지를 벗어나지 않은 범위내에서In addition, the present invention is provided within the scope without departing from the scope of the claims.

어느 한 종류에 한정하지 않고 변이되며 멸균이 필요한 필요용도에 따라 다종류의 항생약제 와 영양제,미네랄을 혼재하여 적용 할 수 있는 것이고 멸균포장(2)은 햇빛 차단되는 유리앰플 또는 연질튜브로 진공밀폐하여 이루어지며 기타기능이 추가 될 수 있다It is not limited to any one type, and it can be applied by mixing various types of antibiotics, nutrients and minerals according to the necessary use requiring sterilization. and other functions can be added

Claims (7)

본 발명은 과산화수소를 산화철분 또는 헤모글로빈에 반응시켜 발생한 산소를 포함한 과산화수소를 산화반응시켜 발생한 물질(3)을 주사용증류수(1)에 혼재시켜 멸균포장(2)하여 제조하고 동물이나 인체의 정맥에 주사하여
감염된 바이러스를 멸균시켜 감염된 질환을 치료하는 주사약품 시스템을 특징으로 하는
과산화수소를 산화반응시켜 발생한 물질을 정맥주사하여 바이러스를 멸균시키는 약재시스템,The present invention is prepared by mixing a substance (3) generated by an oxidative reaction of hydrogen peroxide containing oxygen generated by reacting hydrogen peroxide with iron oxide or hemoglobin in distilled water for injection (1), sterilized and packaged (2), and administered to an animal or human vein. by injection
An injection drug system that sterilizes an infected virus to treat an infected disease.
A drug system that sterilizes viruses by intravenously injecting substances generated by oxidizing hydrogen peroxide, 제1항에 있어서
첫째, 35%이하의 과산화수소를 중량대비 80% 이상으로 하고 산화철분 또는 헤모글로빈을 중량대비20% 이하로 반응 용기에 담아 혼재하면서 반응시켜 산화반응시켜 발생한 물질(3)을 추출하는 단계 와
둘째,산화반응시켜 발생한 물질(3)을 추출하여 주사용증류수(1)에 혼재시켜 멸균포장(2)하여 완성약품을 제조하는 단계로 제조 된 것을 특징으로 하는
과산화수소를 산화반응시켜 발생한 물질을 정맥주사하여 바이러스를 멸균시키는 약재시스템,The method of claim 1
First, 35% or less of hydrogen peroxide is made 80% or more by weight, and iron oxide or hemoglobin is placed in a reaction vessel at 20% or less by weight and reacted while mixing to extract the material (3) generated by oxidation reaction;
Second, extracting the material (3) generated by the oxidation reaction, mixing it with distilled water for injection (1), sterilizing packaging (2), characterized in that it was manufactured in the step of manufacturing the finished drug
A drug system that sterilizes viruses by intravenously injecting substances generated by oxidizing hydrogen peroxide, 제1항에 있어서
제조 된 완성약품을 동물이나 인체의 정맥에 주사하여 감염된 바이러스를 멸균시켜 감염된 질환을 치료하는 주사약품 시스템을 특징으로 하는
과산화수소를 산화반응시켜 발생한 물질을 정맥주사하여 바이러스를 멸균시키는 약재시스템,The method of claim 1
It features an injection drug system that sterilizes the infected virus by injecting the manufactured drug into a vein of an animal or human body to treat an infected disease.
A drug system that sterilizes viruses by intravenously injecting substances generated by oxidizing hydrogen peroxide, 제1항에 있어서
산화반응시켜 발생한 물질(3)을 인체 장기에 흐르는 혈액의 흐름을 따라 이송시켜 인체의 세포에 물질이동시켜 흡습시키고 용존산소량을 대폭증대시켜 세포의 염증물질을 제거하면서 세포의 면역력을 극대화 시키는 기능과
장기내 상처를 보호 하고 세포의 2차감염을 방지하는 것을 특징으로 하는
과산화수소를 산화반응시켜 발생한 물질을 정맥주사하여 바이러스를 멸균시키는 약재시스템,The method of claim 1
The function of maximizing the immunity of cells while removing inflammatory substances from cells by transporting the substances (3) generated by oxidation reaction along the flow of blood flowing through the organs of the body, moving the substances to the cells of the body to absorb moisture, and greatly increasing the amount of dissolved oxygen.
It is characterized in that it protects internal wounds and prevents secondary infection of cells.
A drug system that sterilizes viruses by intravenously injecting substances generated by oxidizing hydrogen peroxide, 제1항에 있어서
세균이나 변종 또는 신종바이러스의 단백질을 파괴하여 변종 또는 신종바이러스 활동 할 수 없는 조건을 제시하여 멸균시키는 것을 특징으로 하는
과산화수소를 산화반응시켜 발생한 물질을 정맥주사하여 바이러스를 멸균시키는 약재시스템,The method of claim 1
It is characterized by sterilization by destroying the protein of bacteria, mutant or new virus to present conditions in which the mutant or new virus cannot be active.
A drug system that sterilizes viruses by intravenously injecting substances generated by oxidizing hydrogen peroxide, 제1항에 있어서
발생된 산소는 폐를 비롯한 호흡기에 자연분산 공급시켜 생명을 구하는 기능으로 이루어지는 것을 특징으로 하는
과산화수소를 산화반응시켜 발생한 물질을 정맥주사하여 바이러스를 멸균시키는 약재시스템,The method of claim 1
Oxygen generated is naturally distributed and supplied to the respiratory system including the lungs, characterized in that it has a life-saving function.
A drug system that sterilizes viruses by intravenously injecting substances generated by oxidizing hydrogen peroxide, 제1항에 있어서
과산화수소를 산화반응시켜 발생한 물질(3)을 약품으로 제조하여 정맥주사 하였을때 혈액에 잔류하는 미량의 과산화수소 성분은 혈액이 보유한 염소에 의하여 중화되고 배설물로 배출되는 것을 특징으로 하는
과산화수소를 산화반응시켜 발생한 물질(3)을 정맥주사하여 바이러스를 멸균시키는 약재시스템,The method of claim 1
When the substance (3) generated by the oxidation reaction of hydrogen peroxide is manufactured as a drug and injected intravenously, the trace amount of hydrogen peroxide remaining in the blood is neutralized by chlorine in the blood and discharged as excrement.
A drug system that sterilizes the virus by intravenously injecting the substance (3) generated by the oxidation reaction of hydrogen peroxide,
KR1020200038156A 2020-03-27 2020-03-27 A drug system that sterilizes viruses by intravenously injecting substances generated by oxidation reaction of hydrogen peroxide KR20210120761A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020200038156A KR20210120761A (en) 2020-03-27 2020-03-27 A drug system that sterilizes viruses by intravenously injecting substances generated by oxidation reaction of hydrogen peroxide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020200038156A KR20210120761A (en) 2020-03-27 2020-03-27 A drug system that sterilizes viruses by intravenously injecting substances generated by oxidation reaction of hydrogen peroxide

Publications (1)

Publication Number Publication Date
KR20210120761A true KR20210120761A (en) 2021-10-07

Family

ID=78609566

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020200038156A KR20210120761A (en) 2020-03-27 2020-03-27 A drug system that sterilizes viruses by intravenously injecting substances generated by oxidation reaction of hydrogen peroxide

Country Status (1)

Country Link
KR (1) KR20210120761A (en)

Similar Documents

Publication Publication Date Title
Zenk et al. Nafcillin extravasation injury: use of hyaluronidase as an antidote
CN104306981A (en) Preparation method of anti Helicobacter pylori active antibacterial peptide gastric mucosa nanoparticle delivery system
KR20210120761A (en) A drug system that sterilizes viruses by intravenously injecting substances generated by oxidation reaction of hydrogen peroxide
KR20210121825A (en) A drug system that sterilizes viruses by subcutaneously injecting substances generated by the oxidation reaction of hydrogen peroxide
CN102614294B (en) Compound amoxicillin suspension injection and preparation method thereof
Hartley et al. Use of antibiotic impregnated polymethylmethacrylate beads for the treatment of chronic mandibular osteomyelitis in a Bennett's wallaby (Macropus rufo‐griseus rufogriseus)
Banerjee et al. Bees make medicine for mankind
Mishra et al. The rising Havoc of the black, white and Yellow fungi in India
DeEds et al. Studies on phenothiazine. IX. The biliary excretion and anthelmintic action of thionol
Martelli et al. Long-term deep sedation using Zoletil and haloperidol for the treatment of streptococcal pneumonia in an orangutan (Pongo pygmaeus)
KR20210127047A (en) Vaccine Convergence Manufacturing System Using Hydrogen Peroxide
Ramakrishnan et al. The management of anaerobic infection in extensive burns
WO2007143586A2 (en) Composition for wound care and method of using same
Arioli et al. Activity of teicoplanin in localized experimental infections in rats
KR20210121826A (en) A system for necrosis of cancer cells by injecting a substance generated by oxidative reaction of hydrogen peroxide with saccharides into cancer tissue
KR20220032987A (en) Virus treatment system manufactured by legalizing hydrogen peroxide
Sekhon Iodine: A support against infections and emerging as an antibiotic.
KR20210118712A (en) A drug system that kills a mutant virus that collects oxygen-containing air bubbles generated by reacting edible hydrogen peroxide with hemoglobin in solid matter.
Meier et al. Gangrenous Clostridium perfringens infection and subsequent wound management in a rhesus macaque (Macaca mulatta)
KR20220022422A (en) Virus treatment system manufactured by legalizing hydrogen peroxide
CN108721328A (en) Chitosan iodine biomaterial and preparation method thereof
US10342828B1 (en) Fecal oxygenation
KR20210117783A (en) Edible hydrogen peroxide drug system that kills strained viruses that have infected the human body
RU2486892C1 (en) Method of lymphotropic therapy in case of orthodontal abscesses in rabbits
Watson et al. Clostridial Tetani Infection in a Yearling Arabian Colt (Blacky’s Spaz Attack)